Howland Capital Management’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.37M Buy
252,860
+66,861
+36% +$1.68M 0.23% 70
2026
Q1
$4.7M Buy
185,999
+97,740
+111% +$2.49M 0.19% 72
2025
Q4
$2.25M Buy
88,259
+39,166
+80% +$1M 0.09% 107
2025
Q3
$1.26M Buy
49,093
+16,203
+49% +$411K 0.05% 146
2025
Q2
$832K Buy
32,890
+11,388
+53% +$283K 0.03% 166
2025
Q1
$537K Buy
+21,502
New +$532K 0.02% 190

Other funds holding IBDX

Howland Capital Management's IBDX Position: Q2 2026 in Review

Howland Capital Management increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 36% in Q2 2026, buying an estimated $1.68M and bringing the position to 252,860 shares worth $6.37M. The position accounts for 0.23% of the portfolio, ranked #70.

Howland Capital Management first reported a position in IBDX in Q1 2025 and has held it in 6 quarters since. 36 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Howland Capital Management held 252,860 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $6.37M as of Q2 2026.
  • Howland Capital Management bought 66,861 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $1.68M.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.23% of Howland Capital Management's portfolio in Q2 2026, its #70 holding.
  • Howland Capital Management first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q1 2025 and has held it in 6 quarters since.
  • 36 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Howland Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.